Cargando…

(47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes

BACKGROUND: Radiotheragnostics makes use of the same molecular targeting vectors, labeled either with a diagnostic or therapeutic radionuclide, ideally of the same chemical element. The matched pair of scandium radionuclides, (44)Sc and (47)Sc, satisfies the desired physical aspects for PET imaging...

Descripción completa

Detalles Bibliográficos
Autores principales: Domnanich, Katharina A., Müller, Cristina, Benešová, Martina, Dressler, Rugard, Haller, Stephanie, Köster, Ulli, Ponsard, Bernard, Schibli, Roger, Türler, Andreas, van der Meulen, Nicholas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824697/
https://www.ncbi.nlm.nih.gov/pubmed/29503846
http://dx.doi.org/10.1186/s41181-017-0024-x
_version_ 1783302069503918080
author Domnanich, Katharina A.
Müller, Cristina
Benešová, Martina
Dressler, Rugard
Haller, Stephanie
Köster, Ulli
Ponsard, Bernard
Schibli, Roger
Türler, Andreas
van der Meulen, Nicholas P.
author_facet Domnanich, Katharina A.
Müller, Cristina
Benešová, Martina
Dressler, Rugard
Haller, Stephanie
Köster, Ulli
Ponsard, Bernard
Schibli, Roger
Türler, Andreas
van der Meulen, Nicholas P.
author_sort Domnanich, Katharina A.
collection PubMed
description BACKGROUND: Radiotheragnostics makes use of the same molecular targeting vectors, labeled either with a diagnostic or therapeutic radionuclide, ideally of the same chemical element. The matched pair of scandium radionuclides, (44)Sc and (47)Sc, satisfies the desired physical aspects for PET imaging and radionuclide therapy, respectively. While the production and application of (44)Sc was extensively studied, (47)Sc is still in its infancy. The aim of the present study was, therefore, to investigate and compare two different methods of (47)Sc production, based on the neutron irradiation of enriched (46)Ca and (47)Ti targets, respectively. METHODS: (47)Sc was produced by thermal neutron irradiation of enriched (46)Ca targets via the (46)Ca(n,γ)(47)Ca → (47)Sc nuclear reaction and by fast neutron irradiation of (47)Ti targets via the (47)Ti(n,p)(47)Sc nuclear reaction, respectively. The product was compared with regard to yield and radionuclidic purity. The chemical separation of (47)Sc was optimized in order to obtain a product of sufficient quality determined by labeling experiments using DOTANOC. Finally, preclinical SPECT/CT experiments were performed in tumor-bearing mice and compared with the PET image of the (44)Sc labeled counterpart. RESULTS: Up to 2 GBq (47)Sc was produced by thermal neutron irradiation of enriched (46)Ca targets. The optimized chemical isolation of (47)Sc from the target material allowed formulation of up to 1.5 GBq (47)Sc with high radionuclidic purity (>99.99%) in a small volume (~700 μL) useful for labeling purposes. Three consecutive separations were possible by isolating the in-grown (47)Sc from the (46/47)Ca-containing fraction. (47)Sc produced by fast neutron irradiated (47)Ti targets resulted in a reduced radionuclidic purity (99.95–88.5%). The chemical purity of the separated (47)Sc was determined by radiolabeling experiments using DOTANOC achievable at specific activities of 10 MBq/nmol. In vivo the (47)Sc-DOTANOC performed equal to (44)Sc-DOTANOC as determined by nuclear imaging. CONCLUSION: The production of (47)Sc via the (46)Ca(n,γ)(47)Ca nuclear reaction demonstrated significant advantages over the (47)Ti production route, as it provided higher quantities of a radionuclidically pure product. The subsequent decay of (47)Ca enabled the repeated separation of the (47)Sc daughter nuclide from the (47)Ca parent nuclide. Based on the results obtained from this work, (47)Sc shows potential to be produced in suitable quality for clinical application. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s41181-017-0024-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5824697
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-58246972018-02-28 (47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes Domnanich, Katharina A. Müller, Cristina Benešová, Martina Dressler, Rugard Haller, Stephanie Köster, Ulli Ponsard, Bernard Schibli, Roger Türler, Andreas van der Meulen, Nicholas P. EJNMMI Radiopharm Chem Research Article BACKGROUND: Radiotheragnostics makes use of the same molecular targeting vectors, labeled either with a diagnostic or therapeutic radionuclide, ideally of the same chemical element. The matched pair of scandium radionuclides, (44)Sc and (47)Sc, satisfies the desired physical aspects for PET imaging and radionuclide therapy, respectively. While the production and application of (44)Sc was extensively studied, (47)Sc is still in its infancy. The aim of the present study was, therefore, to investigate and compare two different methods of (47)Sc production, based on the neutron irradiation of enriched (46)Ca and (47)Ti targets, respectively. METHODS: (47)Sc was produced by thermal neutron irradiation of enriched (46)Ca targets via the (46)Ca(n,γ)(47)Ca → (47)Sc nuclear reaction and by fast neutron irradiation of (47)Ti targets via the (47)Ti(n,p)(47)Sc nuclear reaction, respectively. The product was compared with regard to yield and radionuclidic purity. The chemical separation of (47)Sc was optimized in order to obtain a product of sufficient quality determined by labeling experiments using DOTANOC. Finally, preclinical SPECT/CT experiments were performed in tumor-bearing mice and compared with the PET image of the (44)Sc labeled counterpart. RESULTS: Up to 2 GBq (47)Sc was produced by thermal neutron irradiation of enriched (46)Ca targets. The optimized chemical isolation of (47)Sc from the target material allowed formulation of up to 1.5 GBq (47)Sc with high radionuclidic purity (>99.99%) in a small volume (~700 μL) useful for labeling purposes. Three consecutive separations were possible by isolating the in-grown (47)Sc from the (46/47)Ca-containing fraction. (47)Sc produced by fast neutron irradiated (47)Ti targets resulted in a reduced radionuclidic purity (99.95–88.5%). The chemical purity of the separated (47)Sc was determined by radiolabeling experiments using DOTANOC achievable at specific activities of 10 MBq/nmol. In vivo the (47)Sc-DOTANOC performed equal to (44)Sc-DOTANOC as determined by nuclear imaging. CONCLUSION: The production of (47)Sc via the (46)Ca(n,γ)(47)Ca nuclear reaction demonstrated significant advantages over the (47)Ti production route, as it provided higher quantities of a radionuclidically pure product. The subsequent decay of (47)Ca enabled the repeated separation of the (47)Sc daughter nuclide from the (47)Ca parent nuclide. Based on the results obtained from this work, (47)Sc shows potential to be produced in suitable quality for clinical application. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s41181-017-0024-x) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-06-02 /pmc/articles/PMC5824697/ /pubmed/29503846 http://dx.doi.org/10.1186/s41181-017-0024-x Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research Article
Domnanich, Katharina A.
Müller, Cristina
Benešová, Martina
Dressler, Rugard
Haller, Stephanie
Köster, Ulli
Ponsard, Bernard
Schibli, Roger
Türler, Andreas
van der Meulen, Nicholas P.
(47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
title (47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
title_full (47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
title_fullStr (47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
title_full_unstemmed (47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
title_short (47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
title_sort (47)sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824697/
https://www.ncbi.nlm.nih.gov/pubmed/29503846
http://dx.doi.org/10.1186/s41181-017-0024-x
work_keys_str_mv AT domnanichkatharinaa 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes
AT mullercristina 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes
AT benesovamartina 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes
AT dresslerrugard 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes
AT hallerstephanie 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes
AT kosterulli 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes
AT ponsardbernard 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes
AT schibliroger 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes
AT turlerandreas 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes
AT vandermeulennicholasp 47scasusefulbemitterfortheradiotheragnosticparadigmacomparativestudyoffeasibleproductionroutes